A plain-language guide for Minnesota
Minnesota
peptide therapy,
in plain words.
Start with the name of the medicine. The phrase “peptide therapy” does not name a single treatment. Ask what the product is, what it is meant to do, and who will check your health.
What does “peptide” mean?
In a peptide, tiny building blocks form a short chain, much like beads strung on a necklace. Proteins are longer chains made from the same kind of blocks. Insulin is a member of the peptide group. “Peptide” tells you about a substance’s structure. It leaves the type of care being offered unclear.
Get the drug’s exact name. Ask which description below matches it.
Same broad label. Very different products.
A medicine with approval
Each medicine is reviewed by the Food and Drug Administration (FDA) for the particular uses being proposed. As of September 26, 2026, semaglutide had FDA approval in products called Ozempic and Wegovy; tirzepatide had it in Mounjaro and Zepbound. Ozempic and Mounjaro have approval for treating type 2 diabetes. Wegovy and Zepbound have approval for weight management: losing weight and keeping it off. Ask whether the exact product has approval for your health problem.
Approval applies only to the named product and its use, rather than everything described as a peptide.
A medicine made to order
With compounding, medicine is made for an individual patient instead of being supplied as a drug company’s finished product. This can fill a gap when an approved medicine does not meet a patient’s medical need.
As of September 26, 2026, federal law allowed a licensed pharmacy to prepare medicine on a valid prescription for an identified patient, with other legal requirements met. A separate legal route lets larger facilities registered with the FDA make batches of medicine without a prescription naming each patient. Ask who will make your medicine and what rules allow that exact version. The Evidence page explains Minnesota's limits on copies of ready-made drugs.
As of September 26, 2026, the FDA had not approved compounded medicines. The FDA has not checked how well they are made, whether they help, or whether they are safe before they are offered.
A product labelled for research
The FDA warned, as of September 26, 2026, against weight-loss drugs with research labels and unknown quality. In the US, BPC-157, ipamorelin and retatrutide had no FDA-approved medicine as of September 26, 2026.
According to the FDA, federal law barred compounding retatrutide as of September 26, 2026.
Where can care begin in Minnesota?
Begin with a visit at a clinic or through a licensed telehealth service. Telehealth means care through video, phone, or another online exchange. Describe the problem you want help with. Ask whether a medicine fits that problem.
For ongoing online care in Minnesota, a doctor needs a Minnesota licence or interstate telehealth registration as of October 1, 2026. That registration lets certain doctors based in other states provide online care under Minnesota rules.
Check the person who will assess you. Check the pharmacy that will fill any prescription. Get clear answers before paying.